This report provides the current prevalent female population for Rett syndrome across 23 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Switzerland, Estonia, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Rett syndrome (RTT) is a rare neurodevelopmental disorder characterised by loss of acquired skills after a period of apparently normal development. It is divided into typical, atypical and variant forms, most of which affect girls. It used to be considered as one of the autism spectrum disorders, but when its aetiology was determined to be an X-linked (rarely autosomal) single-gene mutation, it was removed from that group and is now considered as a separate pathological entity.
Providing a value-added level of insight from the publisher's analysis team, several features of Rett syndrome patients, as well as the main comorbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities of Rett syndrome include: